At a glance
- Originator Abbott GmbH & Co. KG
- Class Antipsychotics
- Mechanism of Action Dopamine D1 receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Psychotic disorders
Most Recent Events
- 13 Mar 2001 BASF's pharmaceutical business has been acquired by Abbott Laboratories
- 31 Jul 1997 Phase-I clinical trials for Psychotic disorders in United Kingdom (unspecified route)
- 18 Mar 1997 Investigation in Psychotic disorders in United Kingdom (unspecified route)